Similarly, there was only a decreasing trend of LYVE-1 and OVA-647 area coverage in the MLVs in 3-month-old APP/PS1 mice, while a marked reduction was found in 11-month-old APP/PS1 mice ( Figure 1 E-F ).
← all excerpts
Unlocking potential of oxytocin: improving intracranial lymphatic drainage for Alzheimer's disease treatment.
1
—
—